High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Shou Hsuan ^a   Li, Yi Jung ^a   Wu, Hsin Hsu ^a   Lee, Cheng Chia ^a   Lin, Chan Yu ^a   Weng, Cheng Hao ^a   Chen, Yung Chang ^a   Chang, Ming Yang ^a   Hsu, Hsiang Hao ^a   Fang, Ji Tseng ^a   Hung, Cheng Chieh ^a   Yang, Chih Wei ^a   Tian, Ya Chung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOALBUMINEMIA; INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PREDICTIVE VALUE; SURVIVAL RATE;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; REGRESSION ANALYSIS; TREATMENT FAILURE;

EID: 84899752635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093063     Document Type: Article

References (55)

1. Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476. (Pubitemid 30124077)
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979. (Pubitemid 27152782)
3. Volanakis JE, Narkates AJ (1981) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol 126: 1820-1825. (Pubitemid 11120965)
4. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, et al. (1998) C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18: 1386-1392. (Pubitemid 28421875)
5. Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL (2011) C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med 123: 114-119.
6. Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, et al. (2010) Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM 103: 837-846.
7. Wang AY, Woo J, Lam CW, Wang M, Sea MM, et al. (2003) Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 14: 1871-1879. (Pubitemid 36750483)
8. Corrado E, Novo S (2007) [High sensitivity of C-reactive protein in primary prevention]. G Ital Cardiol (Rome) 8: 327-334.
9. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, et al. (2000) C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 18: 183-190. (Pubitemid 30619957)
10. Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ (2011) Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol 7: 166-176.
11. Filiopoulos V, Vlassopoulos D (2009) Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 8: 369-382.
12. Wanner C, Drechsler C, Krane V (2009) C-reactive protein and uremia. Semin Dial 22: 438-441.
13. Choi HY, Lee JE, Han SH, Yoo TH, Kim BS, et al. (2010) Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant 25: 1266-1271.
14. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, et al. (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148. (Pubitemid 41828276)
15. Wang AY, Lam CW, Chan IH, Wang M, Lui SF, et al. (2009) Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers. Nephrol Dial Transplant 24: 3826-3833.
16. Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, et al. (2009) Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs 32: 872-882.
17. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, et al. (2005) IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67: 1216-1233. (Pubitemid 40463099)
18. Yeun JY, Kaysen GA (1997) Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 30: 923-927. (Pubitemid 27524361)
19. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, et al. (2001) Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12: 814-821. (Pubitemid 32246710)
20. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM (2002) C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 62: 1417-1422.
21. Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J (2005) Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Adv Perit Dial 21: 154-158.
22. Oh KH, Moon JY, Oh J, Kim SG, Hwang YH, et al. (2008) Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients. Nephrol Dial Transplant 23: 2356-2364. (Pubitemid 351957579)
23. Cho JH, Hur IK, Kim CD, Park SH, Ryu HM, et al. (2010) Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol Dial Transplant 25: 1964-1973.
24. Perez-Flores I, Coronel F, Cigarran S, Herrero JA, Calvo N (2007) Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis. Adv Perit Dial 23: 140-143.
25. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B (2001) Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16: 2240-2245. (Pubitemid 33062151)
26. Zalunardo NY, Rose CL, Ma IW, Altmann P (2007) Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis. Kidney Int 71: 687-692. (Pubitemid 46494567)
27. Westhuyzen J, Mills K, Healy H (2005) Predicting clinical outcomes in peritoneal dialysis patients using small solute modeling. Ann Clin Lab Sci 35: 46-53. (Pubitemid 40396600)
28. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, et al. (1998) Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18: 387-394. (Pubitemid 28484667)
29. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B (1999) Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 19: 17-22. (Pubitemid 29184774)
30. Kaysen GA (2009) Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol 4 Suppl 1: S56-63.
31. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B (2004) Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 24: 327-339. (Pubitemid 39206627)
32. Wanner C, Metzger T (2002) C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 17 Suppl 8: 29-32; discussion 39-40.
33. Stenvinkel P, Lindholm B (2005) C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif 23: 72-78. (Pubitemid 40082247)
34. Lacson E, Jr., Levin NW (2004) C-reactive protein and end-stage renal disease. Semin Dial 17: 438-448.
35. Don BR, Kaysen GA (2000) Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol 13: 249-259. (Pubitemid 30618067)
36. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW (2000) The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 58: 346-352. (Pubitemid 30429881)
37. Jones CH, Newstead CG, Wills EJ, Davison AM (1997) Serum albumin and survival in CAPD patients: the implications of concentration trends over time. Nephrol Dial Transplant 12: 554-558. (Pubitemid 27105634)
38. Owen WF, Jr., Lew NL, Liu Y, Lowrie EG, Lazarus JM (1993) The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006. (Pubitemid 23307908)
39. Kang SH, Cho KH, Park JW, Yoon KW, Do JY (2012) Risk factors for mortality in stable peritoneal dialysis patients. Ren Fail 34: 149-154.
40. Kaul K, Hodgkinson A, Tarr JM, Kohner EM, Chibber R (2010) Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr Diabetes Rev 6: 294-303.
41. Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab.
42. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, et al. (1998) Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292. (Pubitemid 28283893)
43. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG (2006) Metaanalysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17: 2591-2598. (Pubitemid 44300976)
44. Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, et al. (2009) Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 24: 2909-2914.
45. Fine A (2002) Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 61: 615-620.
46. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B (2003) Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 18: 590-597. (Pubitemid 36305667)
47. Ates K, Ates A, Ekmekci Y, Nergizoglu G (2005) The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int 25: 256-268. (Pubitemid 40724206)
48. Rumpsfeld M, McDonald SP, Johnson DW (2006) Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17: 271-278.
49. Bargman JM, Thorpe KE, Churchill DN (2001) Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12: 2158-2162. (Pubitemid 32880353)
50. Mujais S, Story K (2006) Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl: S21-26. (Pubitemid 44684772)
51. Kavanagh D, Prescott GJ, Mactier RA (2004) Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 19: 2584-2591. (Pubitemid 39360108)
52. Krediet RT, Balafa O (2010) Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 6: 451-460.
53. Li PK, Chow KM (2005) The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit Dial Int 25 Suppl 3: S80-83. (Pubitemid 40883223)
54. Johnson DW, Craven AM, Isbel NM (2007) Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int 11: 1-14. (Pubitemid 46128673)
55. Nolan CR (2005) Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol 16 Suppl 2: S120-127.